ClinicalBiostats

Clinical Trials

See the methods at work.

Statistical analyses of real clinical trials: design, endpoints, results and interpretation, organized by therapeutic area and linked to the methods behind them.

11,687 trials analyzed so far

Trials that use: MMRM (mixed model for repeated measures)

New to this method? Read the tutorial →

4,121 results

WRAPIndependent statistical analysis of Neurocognitive Factors in Substance Use Treatment Response: The Ways of Rewarding Abstinence Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 63NCT03799341
Wright Foot & Ankle Post-Market Observational Study: Complete Statistical AnalysisIndependent statistical analysis of Wright Foot & Ankle Post-Market Observational Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04118894).Phase NAResults postedn = 119NCT04118894
WU197Independent statistical analysis of Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00656851).Phase NAResults postedn = 24NCT00656851
XEN1101 for Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of XEN1101 for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04827901).Phase 2Results postedn = 60NCT04827901
Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation: Complete Statistical AnalysisIndependent statistical analysis of Xenogeneic Collagen Matrix as an Alternative to Free Gingival Grafting for Oral Soft Tissue Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 30NCT01952301
YeapleIndependent statistical analysis of Clinical Efficacy of a Toothpaste on Hypersensitivity Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01040169).Phase NAResults postedn = 79NCT01040169
YELLOW IIIIndependent statistical analysis of Effect of Evolocumab on Coronary Plaque Characteristics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04710368).Phase 4Results postedn = 137NCT04710368
Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City: Complete Statistical AnalysisIndependent statistical analysis of Yo Puedo! Diabetes Self-Management Education + mHealth in Mexico City: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03159299).Phase NAResults postedn = 47NCT03159299
Yoga and Female Concussion: Complete Statistical AnalysisIndependent statistical analysis of Yoga and Female Concussion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07170488).Phase NAResults postedn = 27NCT07170488
YOGAMAT-IIIndependent statistical analysis of Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase I: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 20NCT04646148
Youth Mayo Clinic Anxiety Coach Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Youth Mayo Clinic Anxiety Coach Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02205177).Phase NAResults postedn = 10NCT02205177
Youth-Led Intervention to Improve Blood Pressure: Complete Statistical AnalysisIndependent statistical analysis of Youth-Led Intervention to Improve Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05029687).Phase NAResults postedn = 64NCT05029687
Zaleplon 10mg Capsules Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Zaleplon 10mg Capsules Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00829998).Phase 1Results postedn = 40NCT00829998
ZAPSIndependent statistical analysis of Zip Arthroplasty Patient Satisfaction Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03178266).Phase NAResults postedn = 41NCT03178266
Zero Heat Flux Thermometry System Comparison Trial: Complete Statistical AnalysisIndependent statistical analysis of Zero Heat Flux Thermometry System Comparison Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01670760).Phase NAResults postedn = 20NCT01670760
Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1): Complete Statistical AnalysisIndependent statistical analysis of Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 121NCT03364153
ZOLARMABIndependent statistical analysis of Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03087851).Phase 4Results postedn = 61NCT03087851
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement: Complete Statistical AnalysisIndependent statistical analysis of Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 1,822NCT00869206
ZoMARSIndependent statistical analysis of Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 48NCT01348269
Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 44NCT00582556
Zonisamide vs. Placebo in the Treatment of Alcohol Dependence: Complete Statistical AnalysisIndependent statistical analysis of Zonisamide vs. Placebo in the Treatment of Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00595556).Phase 4Results postedn = 40NCT00595556